A neurosurgeon and team of computer engineers and developers have produced an innovative medical imaging software platform that combines a DICOM viewer for radiology scans with motion sensing as a way to view images in a sterile environment. MotionView was started by Luke Macyszyn, a neurosurgeon at Penn Medicine, along with computer scientists and engineers Madhur […]
By Allyson B. Mullen – On February 18, 2014, the FDA issued the Final Guidance “Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff” (the “Pre-Sub Guidance”). FDA, Guidance for Industry and FDA Staff, Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings […]
Venture capital is highly competitive in the medical devices industry. Some VCs are even moving out of the device and healthcare space. But, in many cases, venture capital really still is the best kind of equity investment to be had in the medical device industry. If you have a high-risk, PMA-route device, a true innovation, […]
While it’s no secret venture capital for the medical device industry is drying up, The Wall Street Journal takes a look at how to fund a medical device in the face of such a rough market. Unfortunately they don’t come up with any new ideas: family investments, corporate venture capital, debt, you know the drill. […]
Mobile technology has dramatically changed how many people and industries do work, and it is revolutionizing medical device sales — or it at least has the potential to. Properly implemented, and especially used in conjunction with medical devices sales CRM systems, mobile devices and apps can improve the efficiency and productivity of sales reps as […]
Edwards Lifesciences (EW) joined BioMedPartners to add $3 million to Middle Peak Medical‘s already oversubscribed Series A round. The funding will go toward commercializing technology to treat mitral valve disease. Lead investors Wellington Partners and Seventure Partners, added to their investment from the first close, which also included High-Tech Gruenderfonds, according to a press release. In […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Department of Defense awarded Medtronic (MDT) $58,026,785 for radiology systems and components for the Army, Navy, Air Force, Marines and federal civilian agencies. This a first year deal with the option to extend the contract for up to six more years. This first one-year contract should be fulfilled by Oct. 25, 2014. For more, click […]
Though lots of venture capital for medtech has evaporated, Versant Ventures now seeks $250 million for its fifth medtech fund. The venture capital firm, which has strong presence in biotech and medtech, has a diverse California and Minnesota-based portfolio that includes medical device companies such as Respicardia, Zyga Technology and Autonomic Technologies. According to a […]
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing and partnering has really taken off over the last few years as pharma and medical device companies have opened their doors and wallets to find innovation outside of their four walls. A new analysis from […]
Although there’s been a trend over the past couple of years of venture investment in biotech going into companies in the later stages of their development, a new report illustrates the result of that trend. Of the 18 venture-backed “big exit” merger and acquisition deals in biotech in 2012 (an eight year high), half were […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
What CEOs want from an investor and what investors think entrepreneurs want are two pretty different things. A survey of CEOs, venture capitalists and limited partners done by the National Venture Capital Association and two marketing/communications firms found that when CEOs look at venture firms, they want an entrepreneur-friendly, trustworthy, collaborative firm. Meanwhile, VCs say […]
Angel investment networks tend to stick to metropolitan cities on the East Coast and West Coast. Why? Most angels see themselves as philanthropic investors and want to invest locally. Startups tend to sprout in places that encourage entrepreneurship and reward it. Traditionally, that has been in cities on the coasts but that is beginning to […]
At a recent FundingPost event gathering together investors and entrepreneurs in Philadelphia, crowdfunding, provisions in the JOBS Act, and angel and venture investment trends were on attendee minds. It’s an interesting time to talk about funding opportunities for startups, particularly in Pennsylvania. Gov. Tom Corbett signed a bill last week for a tax credit program […]
Paul Hartung, CEO of Cognoptix, Inc., a startup that has created a drug-device that could diagnose Alzheimer’s earlier in patients, is also the first person to have a syndicated angel deal in the Northeast. He’s raised more than $20 million for Cognoptix, and worked on the LASIK team at Summit until it was brought through […]
Hard to understand, slow to exit and more than enough risk to go around. Not many investors are brave and smart enough to fund startups working to get new pharmaceuticals, medical devices and therapeutics on the market. To highlight this breed of investors, and to give healthcare entrepreneurs a way to find them, we have […]
